Skip to content

Interactive Voice Response (IVR)-Based Treatment for Chronic Low Back Pain

IVR-based Cognitive Behavior Therapy for Chronic Low Back

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01025752
Enrollment
134
Registered
2009-12-04
Start date
2011-05-31
Completion date
2016-04-30
Last updated
2018-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low Back Pain

Keywords

chronic pain, cognitive behavior therapy, low back pain

Brief summary

The proposed study will test how well an innovative method, interactive voice response (IVR), can be used for delivering an treatment for chronic low back pain. The use of IVR will improve the accessibility of treatment to Veterans. IVR is a computerized interface that allows patients to use their telephone to: 1) obtain pre-recorded didactic information, 2) report data regarding pain-related symptoms and adherence to pain coping skill practice, and 3) receive personalized therapist feedback. Although CBT has been shown to be effective in reducing pain intensity, traditional CBT requires patients to make frequent office visits. The use of IVR will allow Veterans to access CBT from their home via a touch-tone telephone, thereby allowing them to access treatment at their convenience without travel to the VA for an outpatient appointment. Veterans with chronic low back pain will be randomized in equal numbers to receive either standard CBT or IVR-based CBT. Veterans in both conditions will receive 10 session of treatment designed to help them manage their chronic pain using pain coping skills. The primary outcome measure will be pain intensity.

Detailed description

OBJECTIVES: The primary purpose of this study is to test the efficacy of an innovative method, interactive voice response (IVR), for delivering an empirically validated psychological (cognitive behavior therapy \[CBT\]) treatment for chronic pain in order to improve access and sustainability of this intervention. The primary clinical equivalence hypothesis states that Veterans with chronic low back pain (CLBP) receiving IVR-based CBT (ICBT) will demonstrate, relative to standard face-to-face CBT (CBT), equivalent declines in reports of pain intensity as measured by the numeric rating scale at post-treatment and follow-up. The secondary hypothesis states that Veterans with CLBP receiving ICBT, relative to CBT, will demonstrate equivalent declines in reports of pain-related interference and emotional distress at post-treatment and follow-up. RESEARCH DESIGN: A randomized design will be employed in which standard CBT (CBT) is compared to an Interactive CBT (ICBT) treatment condition. Participants will be randomized in equal numbers to both conditions. Repeated assessments of key outcome domains will occur at pretreatment/baseline and at 3 and 6 months following baseline. METHODOLOGY: Subjects will be 230 patients receiving care at the VA Connecticut Healthcare System who report chronic low back pain. The primary criteria for inclusion are constant pain of at least three months duration with at least a moderate level of average pain (i.e., scores of 4 or greater on a 0 (no pain) to 10 (worst pain imaginable) on a numerical rating scale of average pain. All patients must have access to a touch-tone telephone. Excluded will be patients with life threatening or acute physical illness, current alcohol or substance abuse or dependence, current psychosis, suicidal ideation, dementia, and individuals seeking surgical pain treatment. Comprehensive evaluations will be conducted at each assessment interval. Following completion of written consent and an initial baseline evaluation, participants will be randomized to one of the two treatments. Sessions will be audiotaped to ensure the fidelity of the face-to-face CBT sessions and the personalized therapist feedback in the IVR-based CBT condition. Both conditions will involve 10 outpatient therapy sessions with a psychologist trained experienced in the delivery of these treatments. Adherence to coping skill practice will be assessed using IVR for both treatment groups. Analysis of primary and secondary outcome measures will employ mixed-effects models, which will account for the clustering induced by repeated measures on individual patients.

Interventions

BEHAVIORALFace to face cognitive behavior therapy

Ten session face to face cognitive behavior therapy for chronic low back pain

BEHAVIORALIVR based cognitive behavioral therapy

Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy

Sponsors

University of Michigan
CollaboratorOTHER
VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* presence of at least a moderate level of pain (i.e., pain scores of \> or = 4) and presence of pain for a period of \> or = 3 months * ability to participate safely in the walking portion of the intervention as evidenced by ability to walk at least one block * availability of a touch-tone telephone and computer with internet access in the participant's residence * Veteran receiving care at VA Connecticut Healthcare System

Exclusion criteria

* life threatening or acute medical condition that could impair participation (e.g., severe chronic obstructive pulmonary disease, lower limb amputation, terminal cancer); * psychiatric condition (e.g., active substance abuse, psychosis or suicidality) that could impair participation * surgical interventions for pain during their participation in this study * sensory deficits that would impair participation (e.g., hearing loss to a degree that telephone usage is not possible).

Design outcomes

Primary

MeasureTime frameDescription
Change in Numeric Rating Scale of Pain Intensitypost-treatment (12 weeks), 3 and 6 months post-baselineAn 11-point NRS for pain was administered to patients, with 0 representing No Pain and 10 representing Worst Possible Pain. Patients were asked to rate the level of pain that best represented their experience of worst pain, least pain and average pain over the past week. We computed the change from baseline.

Secondary

MeasureTime frameDescription
Change in Roland Morris Disability Questionnairepost-treatment (12 weeks), 3 and 6 months post-baselineThe RMDQ (Roland & Morris, 1983) is a 24-item checklist designed for patients to identify the level of disability and functional status associated with chronic low back pain. Patients are instructed to endorse items that describe their functional status that day. Scores range from 0-24, with higher scores indicating more disability. We computed the change from baseline.
Change in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scalepost-treatment (12 weeks), 3 and 6 months post-baselineThe SF-36V is an adaptation of the Medical Outcomes Study SF-36 (Ware & Sherbourne, 1992) intended to apply to veteran-specific health-related quality of life. The SF-36 can also be divided into two aggregate summary measures the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The lower the score, the more disability, range 0-100. We computed the change from baseline.
Change in Multidimensional Pain Inventory Interference Subscalepost-treatment (12 weeks), 3 and 6 months post-baselineThe interference subscale of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI) assesses pain-related interference with quality of life. Scores ranging from 0-6, with higher scores indicating more interference. We computed the change from baseline.
Change in Beck Depression Inventory-IIpost-treatment (12 weeks), 3 and 6 months post-baselineDepressive symptom severity was assessed using the BDI-II, higher scores indicate more depressive symptomology, range 0-63. We computed the change from baseline.
Change in Pittsburgh Sleep Quality Indexpost-treatment (12 weeks), 3 and 6 months post-baselineThe PSQI assess sleep quality, with lower scores indicating better sleep, range 0 to 21.We computed the change from baseline.
Change in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scalepost-treatment (12 weeks), 3 and 6 months post-baselineThe SF-36V is an adaptation of the Medical Outcomes Study SF-36 (Ware & Sherbourne, 1992) intended to apply to veteran-specific health-related quality of life. The SF-36 can also be divided into two aggregate summary measures the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The lower the score, the more disability, range 0-100. We computed the change from baseline.

Countries

United States

Participant flow

Recruitment details

Veterans with chronic back pain from VA Connecticut Healthcare System and surrounding community areas were recruited from June 2012-July 2015.

Pre-assignment details

Eligibility screening was conducted by the research assistant via interview and medical record review. Participants who enrolled then subsequently found ineligible from further baseline assessment questionnaires were not randomized to a treatment arm, and excluded from the study (i.e. substance abuse, severe depression, cognitive impairment), n=9.

Participants by arm

ArmCount
Arm 1: IVR CBT
Ten session IVR-based cognitive behavior therapy for chronic low back pain IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy
62
Arm 2: F2F CBT
Ten session face to face cognitive behavior therapy for chronic low back pain Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain
63
Total125

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up710
Overall StudyPhysician Decision13

Baseline characteristics

CharacteristicArm 2: F2F CBTTotalArm 1: IVR CBT
Age, Continuous56.7 years
STANDARD_DEVIATION 11.5
57.9 years
STANDARD_DEVIATION 11.6
59.2 years
STANDARD_DEVIATION 11.8
Race/Ethnicity, Customized
Balck, not Hispanic
18 Participants32 Participants14 Participants
Race/Ethnicity, Customized
Hispanic
6 Participants9 Participants3 Participants
Race/Ethnicity, Customized
Other
1 Participants3 Participants2 Participants
Race/Ethnicity, Customized
White, not Hispanic
37 Participants80 Participants43 Participants
Region of Enrollment
United States
63 Participants125 Participants62 Participants
Sex: Female, Male
Female
15 Participants28 Participants13 Participants
Sex: Female, Male
Male
48 Participants97 Participants49 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
14 / 6219 / 63
serious
Total, serious adverse events
1 / 621 / 63

Outcome results

Primary

Change in Numeric Rating Scale of Pain Intensity

An 11-point NRS for pain was administered to patients, with 0 representing No Pain and 10 representing Worst Possible Pain. Patients were asked to rate the level of pain that best represented their experience of worst pain, least pain and average pain over the past week. We computed the change from baseline.

Time frame: post-treatment (12 weeks), 3 and 6 months post-baseline

Population: The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Arm 1: IVR CBTChange in Numeric Rating Scale of Pain Intensity3 months post-baseline-1.23 units on a scale
Arm 1: IVR CBTChange in Numeric Rating Scale of Pain Intensity6 months post-baseline-0.51 units on a scale
Arm 1: IVR CBTChange in Numeric Rating Scale of Pain Intensitypost-treatment (12 weeks)-0.77 units on a scale
Arm 2: F2F CBTChange in Numeric Rating Scale of Pain Intensitypost-treatment (12 weeks)-0.84 units on a scale
Arm 2: F2F CBTChange in Numeric Rating Scale of Pain Intensity6 months post-baseline-0.44 units on a scale
Arm 2: F2F CBTChange in Numeric Rating Scale of Pain Intensity3 months post-baseline-1.00 units on a scale
Comparison: post-treatment (12 weeks) time pointp-value: 0.00795% CI: [-0.67, 0.8]Mixed Models Analysis
Comparison: 3 month post-baseline time pointp-value: <0.000195% CI: [-0.94, 0.49]Mixed Models Analysis
Comparison: 6 month post- baseline time point.p-value: 0.00495% CI: [-0.86, 0.71]Mixed Models Analysis
Secondary

Change in Beck Depression Inventory-II

Depressive symptom severity was assessed using the BDI-II, higher scores indicate more depressive symptomology, range 0-63. We computed the change from baseline.

Time frame: post-treatment (12 weeks), 3 and 6 months post-baseline

Population: The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Arm 1: IVR CBTChange in Beck Depression Inventory-IIpost-treatment (12 weeks)-1.00 units on a scale
Arm 1: IVR CBTChange in Beck Depression Inventory-II3 months post-baseline-0.49 units on a scale
Arm 1: IVR CBTChange in Beck Depression Inventory-II6 months post-baseline0.89 units on a scale
Arm 2: F2F CBTChange in Beck Depression Inventory-II3 months post-baseline0.78 units on a scale
Arm 2: F2F CBTChange in Beck Depression Inventory-II6 months post-baseline1.62 units on a scale
Arm 2: F2F CBTChange in Beck Depression Inventory-IIpost-treatment (12 weeks)-1.25 units on a scale
Comparison: post-treatment (12 weeks time point). (Mean difference of IVR CBT- F2F CBT)p-value: 0.8595% CI: [-2.32, 2.8]Mixed Models Analysis
Comparison: 3 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.495% CI: [-4.27, 1.73]Mixed Models Analysis
Comparison: 6 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.6895% CI: [-4.3, 2.83]Mixed Models Analysis
Secondary

Change in Multidimensional Pain Inventory Interference Subscale

The interference subscale of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI) assesses pain-related interference with quality of life. Scores ranging from 0-6, with higher scores indicating more interference. We computed the change from baseline.

Time frame: post-treatment (12 weeks), 3 and 6 months post-baseline

Population: The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Arm 1: IVR CBTChange in Multidimensional Pain Inventory Interference Subscalepost-treatment (12 weeks)-0.37 units on a scale
Arm 1: IVR CBTChange in Multidimensional Pain Inventory Interference Subscale3 months post-baseline-0.37 units on a scale
Arm 1: IVR CBTChange in Multidimensional Pain Inventory Interference Subscale6 months post-baseline-0.12 units on a scale
Arm 2: F2F CBTChange in Multidimensional Pain Inventory Interference Subscalepost-treatment (12 weeks)-0.04 units on a scale
Arm 2: F2F CBTChange in Multidimensional Pain Inventory Interference Subscale3 months post-baseline-0.02 units on a scale
Arm 2: F2F CBTChange in Multidimensional Pain Inventory Interference Subscale6 months post-baseline-0.09 units on a scale
Comparison: Post-treatment (12 weeks) time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.1295% CI: [-0.74, 0.09]Mixed Models Analysis
Comparison: 3 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.295% CI: [-0.87, 0.18]Mixed Models Analysis
Comparison: 6 months post baseline time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.9395% CI: [-0.57, 0.52]Mixed Models Analysis
Secondary

Change in Pittsburgh Sleep Quality Index

The PSQI assess sleep quality, with lower scores indicating better sleep, range 0 to 21.We computed the change from baseline.

Time frame: post-treatment (12 weeks), 3 and 6 months post-baseline

Population: The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Arm 1: IVR CBTChange in Pittsburgh Sleep Quality Indexpost-treatment (12 weeks)-2.03 units on a scale
Arm 1: IVR CBTChange in Pittsburgh Sleep Quality Index3 months post-baseline-1.33 units on a scale
Arm 1: IVR CBTChange in Pittsburgh Sleep Quality Index6 months post-baseline-0.87 units on a scale
Arm 2: F2F CBTChange in Pittsburgh Sleep Quality Indexpost-treatment (12 weeks)-1.09 units on a scale
Arm 2: F2F CBTChange in Pittsburgh Sleep Quality Index3 months post-baseline-1.21 units on a scale
Arm 2: F2F CBTChange in Pittsburgh Sleep Quality Index6 months post-baseline-1.25 units on a scale
Comparison: post-treatment (12 weeks) time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.1795% CI: [-2.28, 0.4]Mixed Models Analysis
Comparison: 3 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.8695% CI: [-1.39, 1.16]Mixed Models Analysis
Comparison: 6 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.6495% CI: [-1.22, 1.97]Mixed Models Analysis
Secondary

Change in Roland Morris Disability Questionnaire

The RMDQ (Roland & Morris, 1983) is a 24-item checklist designed for patients to identify the level of disability and functional status associated with chronic low back pain. Patients are instructed to endorse items that describe their functional status that day. Scores range from 0-24, with higher scores indicating more disability. We computed the change from baseline.

Time frame: post-treatment (12 weeks), 3 and 6 months post-baseline

Population: The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Arm 1: IVR CBTChange in Roland Morris Disability Questionnairepost-treatment (12 weeks)-2.92 units on a scale
Arm 1: IVR CBTChange in Roland Morris Disability Questionnaire3 months post-baseline-3.38 units on a scale
Arm 1: IVR CBTChange in Roland Morris Disability Questionnaire6 months post-baseline-2.63 units on a scale
Arm 2: F2F CBTChange in Roland Morris Disability Questionnairepost-treatment (12 weeks)-2.42 units on a scale
Arm 2: F2F CBTChange in Roland Morris Disability Questionnaire3 months post-baseline-1.86 units on a scale
Arm 2: F2F CBTChange in Roland Morris Disability Questionnaire6 months post-baseline-2.02 units on a scale
Comparison: post-treatment (12 weeks) time pointp-value: 0.5895% CI: [-2.29, 1.29]Mixed Models Analysis
Comparison: 3 months post-baseline time pointp-value: 0.1295% CI: [-3.46, 0.41]Mixed Models Analysis
Comparison: 6 months post-baseline time pointp-value: 0.5195% CI: [-2.42, 1.2]Mixed Models Analysis
Secondary

Change in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scale

The SF-36V is an adaptation of the Medical Outcomes Study SF-36 (Ware & Sherbourne, 1992) intended to apply to veteran-specific health-related quality of life. The SF-36 can also be divided into two aggregate summary measures the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The lower the score, the more disability, range 0-100. We computed the change from baseline.

Time frame: post-treatment (12 weeks), 3 and 6 months post-baseline

Population: The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Arm 1: IVR CBTChange in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scale3 months post-baseline1.39 units on a scale
Arm 1: IVR CBTChange in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scale6 months post-baseline0.96 units on a scale
Arm 1: IVR CBTChange in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scalepost-treatment (12 weeks)1.67 units on a scale
Arm 2: F2F CBTChange in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scale3 months post-baseline1.01 units on a scale
Arm 2: F2F CBTChange in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scale6 months post-baseline-1.47 units on a scale
Arm 2: F2F CBTChange in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scalepost-treatment (12 weeks)0.42 units on a scale
Comparison: post-treatment (12 weeks) time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.495% CI: [-1.66, 4.16]Mixed Models Analysis
Comparison: 3 months post-baseline. (Mean difference of IVR CBT- F2F CBT)p-value: 0.8195% CI: [-2.82, 3.58]Mixed Models Analysis
Comparison: 6 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.1695% CI: [-0.96, 5.82]Mixed Models Analysis
Secondary

Change in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scale

The SF-36V is an adaptation of the Medical Outcomes Study SF-36 (Ware & Sherbourne, 1992) intended to apply to veteran-specific health-related quality of life. The SF-36 can also be divided into two aggregate summary measures the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The lower the score, the more disability, range 0-100. We computed the change from baseline.

Time frame: post-treatment (12 weeks), 3 and 6 months post-baseline

Population: The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)
Arm 1: IVR CBTChange in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scalepost-treatment (12 weeks)2.20 units on a scale
Arm 1: IVR CBTChange in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scale3 months post-baseline2.05 units on a scale
Arm 1: IVR CBTChange in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scale6 months post-baseline1.50 units on a scale
Arm 2: F2F CBTChange in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scalepost-treatment (12 weeks)1.91 units on a scale
Arm 2: F2F CBTChange in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scale3 months post-baseline0.90 units on a scale
Arm 2: F2F CBTChange in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scale6 months post-baseline2.09 units on a scale
Comparison: post-treatment (12 weeks) time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.8395% CI: [-2.3, 2.87]Mixed Models Analysis
Comparison: 3 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.4295% CI: [-1.68, 3.98]Mixed Models Analysis
Comparison: 6 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)p-value: 0.6895% CI: [-3.4, 2.24]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026